Drug recall · August 2, 2023
Diclofenac Sodium Topical Solution USP recall
Why: Defective Delivery System
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Diclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only, Manufactured for: Alembic Pharmaceuticals, Inc. Bedminster, NJ 07921, USA Manufactured by: Alembic Pharmaceuticals Limited (Derma Division) Karakhadi, Vadodara 391450, India. NDC 62332-487-12
- Lots / codes
Lot #: 220151, 220152, 220153, Exp. Date 11/2024
- Quantity
- 2844 units
- Company
- Alembic Pharmaceuticals, Inc., Bedminster, NJ
- Distribution
- Nationwide within the United States
- Initiated
- June 22, 2023 · Voluntary: Firm initiated
- Classified
- July 24, 2023
- Reported
- August 2, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diclofenac
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.